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Abstract
Objectives: To determine the efficacy of a new saliva substitute in spray form, for patients with dry mouth.
Study design: Thirty-seven patients with dry mouth were selected (16 males and 21 females), with an age of over 60 years 
and meeting the following inclusion criteria: xerostomia and hyposialia confirmed by sialometry (resting whole saliva / 
stimulated whole saliva). A new artificial saliva in spray format was applied, with evaluation of the degree of improvement 
(VAS scale), frequency of application, time to improvement in minutes, duration in minutes, and assessment of organoleptic 
properties.
Results: Twenty of the 37 patients showed almost immediate improvement after application. The mean number of appli-
cations/day was 3.89, with a mean duration of effect of 15.3 min. (65% > 15 min.). The flavor was rated as pleasant by 18 
patients.
Conclusions: Application of the spray is simple and effective, affording immediate relief, and with reasonable acceptance 
among patients with dry mouth.
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Introduction
Subjective dry mouth sensation is known as xerostomia, 
though when sialometry objectively demonstrates a saliva 
flow rate of under 0.1-0.2 ml/min (resting whole saliva) 
and under 0.7 ml/min (stimulated whole saliva), the term 
hyposialia, sialopenia or salivary hyposecretion is used (1-4). 
This condition is equivalent to the secretion of less than 500 
ml of saliva a day. 
The diagnosis of hyposialia must be based on all the case 
history elements that may be directly implicated in alteration 
of the salivation reflex (5). The salivary glands should be ex-
plored, with the observation of saliva secretion in response to 
massage and drainage of the major salivary glands. However, 
sialometry is the most conclusive technique for both resting 
and stimulated whole saliva. If duct obstructions or calculi are 
suspected, gland sialography is indicated. If an autoimmune 
disease is suspected, a minor salivary gland biopsy of the lip 
should be made, with the determination of antibodies (6).
In patients with chronic hyposialia, the oral mucosa appears 
dry as a result of diminished lubrication. This leads to patient 
discomfort and the first manifestations of dysfunction that 
markedly affect quality of life, such as speech, chewing or 
swallowing difficulties (7), and even impaired taste sensation. 
Likewise, these patients are more susceptible to oral infec-
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tions due to the adverse effects of diminished saliva output 
upon the oral ecosystem (8). There is a direct relationship 
between diminished salivation and the appearance of dental 
caries and halitosis. The caries in such situations evolve 
rapidly and are typically located in the region of the dental 
neck. The development of chronic erythematous candidiasis 
is also frequent on the back of the tongue, along with angle 
cheilitis (5).
The appearance of hyposalivation and/or subjective dry 
mouth can be due to a number of causes, though in general 
the condition results from inhibition of the salivation reflex or 
alterations of the salivary glands. The associated factors inclu-
de the use of different drugs, psychopathological alterations 
and other disorders such as autoimmune diseases (Sjögren’s 
syndrome) or radiotherapy for head and neck cancer (9).
The prevalence of xerostomia is high among the general 
population, and increases with age – affecting approximately 
30% of all individuals over age 65 years. Very possibly, such 
a high incidence in this elderly population is due to the co-
existence of several etiological factors such as the presence of 
chronic diseases, and multiple and chronic drug use (10,11). 
Thus, xerostomia among the elderly is not fundamentally a 
physiological condition but rather a consequence of disease 
or of the side effects of medication. This in turn complicates 
the wearing of dentures, and can cause the latter to produce 
mucosal irritation (12).
The treatment of dry mouth first must be planned by adopting 
an etiological approach. Secondly, salivary stimulation must 
be attempted by means of sialogogues, and salivary substi-
tutes should be used in all cases to avoid the generation of 
symptoms and deterioration of the oral tissues (13,14).
Saliva substitutes constitute palliative and coadjuvant 
treatments that are the option of choice in the case of patients 
with chronic dry mouth. Such artificial salivas fundamenta-
lly act by humidifying and lubricating the dehydrated oral 
mucosa (15). Likewise, they protect the oral cavity against 
irritation, and facilitate mechanical functions such as speech 
and swallowing, among others. Saliva substitutes mainly 
consist of aqueous solutions containing the same mineral 
salts as those found in human saliva. As such, they mimic the 
natural functions of these elements in the oral cavity (16,17). 
Salts such as phosphates and calcium ions in particular exert 
a key buffering effect to normalize the oral pH and avoid 
chemical dissolution of the dental enamel, while restoring 
the demineralization / remineralization balance of the teeth 
(18-20). Artificial salivas also usually contain enzymes with 
antimicrobial action, or mucins as lubricants. Likewise, these 
formulations sometimes contain elements that afford extra 
protection, avoiding buccodental over-colonization and thus 
the development of caries (21).
The present study was designed to demonstrate the subjective 
improvement afforded by a new artificial saliva in spray form 
containing an aqueous solution of mineral salts, xylitol and 
citric acid, in elderly patients with dry mouth.
Material and Methods
A descriptive study was made of 37 patients between 60-77 
years of age (mean 65 years) seen in our Service with a history 
of dry mouth, and who met the inclusion criteria and gave 
informed consent to participation in the study. There were 16 
males and 21 females. All patients presented hyposialia as 
confirmed by resting whole saliva (RWS) <0.1 ml/min and 
stimulated whole saliva (SWS) <0.7 ml/min.
- Two inclusion criteria were established:
1) Dry mouth sensation (xerostomia), as verified by questio-
ning of the patient during the anamnesis.
2) Objective prior sialometric confirmation of hyposialia 
based on the resting whole saliva (RWS) and stimulated 
whole saliva values (SWS). This criterion was used to ensure 
homogeneity of the study sample. Two sialometric evalua-
tions were made on different days. The drainage technique 
was used, collecting saliva in the morning after at least two 
hours without food or drink, or smoking.
Following the duplicate resting and stimulated sialometric 
tests, mean resting whole saliva values of RWS1 = 0.11±0.07 
ml/min and RWS2 = 0.13±0.12 ml/min were obtained, with 
mean stimulated whole saliva values of SWS1 = 0.39±0.19 
ml/min and SWS2 = 0.40±0.15 ml/min.
The objective of the present study was to evaluate the sub-
jective improvement afforded by a new artificial saliva for-
mulation fundamentally composed of an aqueous solution of 
potassium thiocyanate, potassium chloride, sodium chloride, 
calcium chloride, magnesium chloride, potassium dihydrogen 
phosphate, xylitol and citric acid.
The solution was supplied in spray format for more conve-
nient administration during the day to improve oral mucosal 
hydration. The patients were required to use the product for 
7 days, as often as required according to the intensity of oral 
dryness, and with a minimum frequency of two applications 
a day. A questionnaire was supplied for recording informa-
tion on the perceived effects of the product. In this way, the 
degree of improvement (reduction of dry mouth sensation) 
was rated by a visual analog scale (VAS) from 0-10 (0 = no 
improvement; 10 = total improvement). The patients were 
also questioned about the frequency of application of the 
spray, the time to onset of improvement (in minutes), and 
the duration of improvement. Finally, their opinion was 
requested regarding the organoleptic properties of the for-
mulation (particularly flavor), likewise rated on a VAS from 
0-10. A descriptive analysis of the data was made, reporting 
the results as absolute frequencies and percentages for each 
study variable.
Results
All the patients (n=37) selected for this study presented 
some antecedent of disease characteristic of the age invol-
ved. A total of 29 patients were receiving medication for 
the treatment and/or prevention of such disease. The most 
common pathologies in this sense were hypertension, type 2 
diabetes, depression and rheumatic problems. Almost one half 
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of the subjects (n=15) were using some psychoactive drug 
for anxiety or depression, and three subjects had received 
radiotherapy for head and neck cancer.
All the subjects complained of dry mouth, with difficulties for 
basic oral functions such as speech, eating or swallowing.
Twenty patients (54%) reported some improvement after 
using the spray. Such improvement was immediate in 19 
cases, while one patient reported improvement after one mi-
nute. There was no relationship between such improvement 
and the background disease or drug use.
All the patients applied the product at least twice a day, and 
a maximum of 7 times a day (mean 3.89 daily applications). 
A total of 54% of the patients used the spray three or four 
times a day.
The duration of the humidification effect ranged from 6-28 
minutes, with an average of 15.3 minutes. In 90% of the cases 
the duration of the effect was 10 minutes or more, while in 
65% of the cases the effect lasted for 15 minutes or more.
The flavor of the solution was favorably rated by 18 patients, 
with a mean score of 7.45 among those who noted improve-
ment after using the spray. No adverse effects were associated 
with the use of the product.
Discussion
Dry mouth is a common problem among elderly patients seen 
in dental practice. When this problem becomes chronic, it can 
lead to important oral pathology, with an increased risk of 
infections and rampant caries. On the other hand, hyposialia 
has a marked negative effect upon patient quality of life, as 
a result of the impairment of oral functions (22). As has been 
reported by Bergdahl and Bergdahl (2), age and medication 
play a very important role in patients with hyposialia.
As has been commented by Guijarro et al. (1), when treating 
dry mouth it is important not to forget the adoption of preven-
tive measures to reduce the complications. It is also important 
to evaluate the existing functional salivary gland parenchyma, 
to allow mechanical, chemical or gustative stimulation (23). 
Such low intensity stimulation of the salivary glands can 
be achieved with simple measures such as xylitol chewing 
gum, sugar-free essence-containing sweets, increasing the 
frequency of meals, or encouraging the consumption of aci-
dic beverages (5). However, when these measures no longer 
prove effective, other options must be sought. In this context, 
use can be made of drugs that stimulate secretion, such as 
pilocarpine in droplets or tablet form, though the associated 
undesirable effects are highly varied and frequent (24). These 
characteristics preclude such treatment in patients with hypo-
sialia secondary to chronic illnesses or the administration of 
multiple drug substances. As a result, in these patients, which 
constitute the great majority of subjects with dry mouth, and 
particularly in those over 65 years of age, saliva substitutes 
represent the best palliative management option – though no 
ideal artificial saliva has been developed to date (25). These 
formulations replace the components and functions inherent 
to natural saliva, which are lost to one degree or other as 
a result of dry mouth. Thanks to their lack of undesirable 
effects, saliva substitutes can be used for prolonged periods 
of time as palliative or coadjuvant treatment, depending on 
the severity of hyposialia (26). Likewise, these products 
can be used as often as considered necessary, and are thus 
adaptable to the needs of each individual patient, and to the 
degree of oral dryness.
The product evaluated in the present study is an artificial 
saliva containing mineral salts and ingredients needed for 
maintaining a correct buffer effect and for ensuring the re-
mineralization of dental enamel – which according to Moore 
and Guggenheimer (11) are the specifications required for the 
palliative management of xerostomia. However, the spray 
also contains saliva-stimulating elements such as xylitol and 
citric acid, though its most important effect is lubrication of 
the oral mucosa (27).
The spray format in turn facilitates administration among pa-
tients not used to such treatments, or with problems for using 
other alternatives (e.g., chewing gum), particularly elderly 
patients with disabilities or who wear dentures. 
The study patients had been selected from a larger cohort 
of elderly individuals in which dry mouth was identified 
from the case history and posteriorly confirmed by duplicate 
sialometric determinations of RWS and SWS. Most of the 
subjects, with 3-4 daily applications of the product, found 
the spray format to be convenient and easier to use than 
other formulations such as oral rinses. Likewise, most of the 
patients found the product flavor to be pleasant. In turn, the 
very favorable acceptance of the product probably contributes 
to improve treatment compliance. In effect, as pointed out 
by Gerdin et al. (3), the great majority of patients that need 
saliva substitutes are elderly people, and thus require easy 
access and use of the treatment (28).
It should be noted that those patients who reported improve-
ment of dry mouth with the use of the product experienced 
effect almost immediately, with an important mean duration 
of the latter. The lack of side effects allowed repeated applica-
tion of the spray as many times as desired, with prolongation 
of symptoms relief and thus of the beneficial effects for the 
oral cavity.
In conclusion, it is considered that this saliva substitute in 
spray format is simple to use and is clinically effective, with 
the provision of immediate relief from the symptoms of 
dry mouth. Improved oral health and comfort among these 
patients is thus afforded.
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